MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0825
-0.0063 (-7.09%)
At close: Aug 28, 2026

MariMed Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
163.82159.83157.71148.6134.01121.46
Revenue Growth
4.51%1.34%6.13%10.89%10.33%138.66%
Gross Profit
58.3757.8862.6165.9263.9666.26
Operating Income
-1.86-2.333.5615.0821.3326.86
Net Income
-14.95-14.48-12.47-16.0313.477.23
Earnings Per Share
-0.04-0.04-0.03-0.040.040.02
EPS Growth
----99.41%149.07%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.548.887.2814.739.8629.93
Total Debt
90.6885.3688.4780.1335.8624.37
Net Cash (Debt)
-84.14-76.48-81.19-65.39-265.57
Net Cash Growth
------
Net Cash Per Share
-0.21-0.20-0.21-0.18-0.070.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
9.277.76.797.917.3135.86
Capital Expenditures
-1.26-1.17-11.96-20.13-12.14-17.87
Free Cash Flow
8.016.53-5.18-12.22-4.8317.98
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.63%36.22%39.70%44.36%47.73%54.55%
Operating Margin
-1.14%-1.46%2.26%10.15%15.92%22.12%
Pretax Margin
-6.21%-6.80%-2.71%-4.44%14.56%19.61%
Profit Margin
-9.13%-9.06%-7.90%-10.79%10.05%5.95%
FCF Margin
4.89%4.08%-3.28%-8.22%-3.60%14.80%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----8.9839.95
Forward PE
-20.6620.6620.666.4821.63
P/FCF Ratio
4.155.71---16.05
PS Ratio
0.200.230.280.700.902.38